Abstract
Anaplastic oligodendroglioma (AO) is rare in children. Treatment typically consists of varying combinations of surgery, chemotherapy, and radiotherapy. We present a pediatric case of frontal lobe AO with periventricular subcallosal extension and local leptomeningeal involvement. The isocitrate dehydrogenase (IDH) wild-type tumor was MGMT methylated and contained an ATRX mutation, BRAF alteration, and 1p/19q co-deletion; a combination of alterations mostly encountered in pediatric oligodendrogliomas. The patient underwent a near total resection and had a complete, durable response to temozolomide alone, suggesting that conservative management without radiation may be appropriate in some cases. We review the literature of this uncommon subtype of glioma in children.
Original language | English (US) |
---|---|
Article number | e26708 |
Journal | Pediatric Blood and Cancer |
Volume | 64 |
Issue number | 12 |
DOIs | |
State | Published - Dec 2017 |
Externally published | Yes |
Keywords
- 1p19q
- children
- codeletion
- oligodendroglioma
- pediatric
- temozolomide
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Hematology
- Oncology